GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Adherium ADR.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.05

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Adherium — daily ASX:ADR

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Adherium on TradingView ↗
Market value
A$160.7m
Last close × shares
Volume
276.1k
Shares, 9 Nov 2026

About Adherium

Its shares trade on ASX under the ticker ADR.AX. It has been listed since 26 August 2015. In the fiscal year to 30 June 2026, it reported revenue of A$2.1m and a net loss of A$14.2m. At that date it held total assets of A$4.6m and shareholders' equity of −A$1.3m.

Adherium Ltd. engages in the development, manufacture, and supply of connected medical devices and respiratory medications used by patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-26. The firm is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.

Figures and description from our data supplier, not checked against the company's own report.

More about Adherium →

Latest on Adherium

Our reporting

We have not reported on Adherium yet.

Next results

26 Feb 2027

Due on 26 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Adherium's ticker?

Adherium trades as ADR.AX on ASX, under ISIN AU000000ADR1.

What was Adherium's last closing price?

0.05 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Adherium next report results?

Results are expected on 26 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.